Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
Date:12/20/2010

ized and 219 patients were treated with balanced distribution over five groups.  The control group received macular laser therapy at baseline, and patients were eligible for repeat laser treatments, but no more frequently than at 16 week intervals.  Two groups received monthly doses of 0.5 or 2mg of VEGF Trap-Eye throughout the 12-month dosing period.  Two groups received three initial monthly doses of 2mg of VEGF Trap-Eye (at baseline and weeks 4 and 8), followed through week 52 by either every two months dosing or PRN (as-needed) dosing with very strict repeat dosing criteria. Mean gains in visual acuity versus baseline were as follows:Laser

0.5mg

monthly

2mg

monthly

2mg

every two

months*

2mg

PRN*n

44

44

44

42

45Mean change in visual acuity at week 24 versus baseline(1) (letters)

2.5

8.6**

11.4**

8.5**

10.3**Mean change in visual acuity at week 52 versus baseline (letters)

-1.3

11.0**

13.1**

9.7**

12.0***Following 3 initial monthly doses

**p<0.01 versus laser

(1) Primary endpointNo significant differences among the VEGF Trap-Eye arms were observed.  Approximately 80 percent of the VEGF Trap-Eye patients and 75 percent of the laser patients remained in the study through 52 weeks.

VEGF Trap-Eye was generally well-tolerated, and there were no ocular or non-ocular drug-related serious adverse events reported in the study.  The most common adverse events reported were those typically associated with intravitreal injections or the underlying disease. The most frequent ocular adverse events reported among patients receiving VEGF Trap-Eye included conjunctival hemorrhage, eye pain, ocular redness (hyperemia), and increased intraocular pressure.  The incidence of non-ocular serious adverse events was generally well balanced between all treatment arms. 
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
(Date:8/29/2014)... JORDAN, Utah , Aug. 29, 2014  BC ... Solutions, has acquired Polaris Medical Imaging, a leader in ... scanners. This strategic acquisition allows BC Technical to continue ... capabilities, specifically within MR and CT modalities. ... cost service," said Mark Alvarez , president and ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2BC Technical Acquires Polaris Medical Imaging 2
... Royal Philips Electronics (AEX: PHI, NYSE: ... mammography (FFDM) solution that offers a lower radiation dose, ... quality. The addition of MicroDose to Philips, already robust ... company,s focus on women,s health care, and underscores its ...
... Althera Medical Ltd. announced today that it intends to ... cancer tumors with alpha radiation at Israel,s eminent Rabin ... Oncology at the Sourasky Medical Center and Althera,s Chief ... Head and Neck Tumor Service at Rabin,s Beilinson Hospital ...
Cached Medicine Technology:Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women's Health Care 2Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women's Health Care 3Philips Enters North American Mammography Market, Underscoring its Global Commitment to Women's Health Care 4Major Israeli Institution Selected to Lead Human Clinical Trials for Revolutionary Alpha Radiation Cancer Therapy 2
(Date:8/30/2014)... 2014 Top10BestSEOHosting.com is a well-known ... announced that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the ... Also, they has announced that Bluehost and Arvixe ... Hostgator, one of the Top 10 Web Hosting ... Windows hosting, and it offers rich features and ...
(Date:8/30/2014)... Astoria, New York (PRWEB) August 30, 2014 ... head, back and shoulder pain in our society and ... as lost production costs, it’s vital that continuing education ... with its goal to help physical therapists help others, ... through September 2nd. , Three learning styles ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Jake W., 18, ... while in the Back2Basics Outdoor Adventures transition program ... finish high school so I can actually start on a ... and math, and I'm done.” , He has six months ... Back2Basics program. Most clients choose to continue on to the ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 “In 2013, a ... The Jones Firm says in a recently released article on ... person was injured in an auto accident every 12 minutes, ... minutes,” they continue. “Based on the 2013 statistics, between now ... vehicle collision.” , The threat of an auto accident is ...
(Date:8/30/2014)... 2014 Zensah®, the leader in compression technology ... Sleeve . The camo sleeves are the first released as ... The camo line includes classic colors like army green and ... Known as tibial stress syndrome, shin splints cause dull aches ... Swollen and irritated muscles, stress fractures, or over pronation may ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:Startling Washington Auto Accident Statistics Discussed In Recently Released Article By The Jones Firm 2Health News:Camo Compression Leg Sleeves Provide Shin Splint Relief for Runners 2
... gloss, depth of image, and surface ... Texas, Oct. 22 Solvay Engineered Polymers,Inc., has ... in the,production of extruded sheet. The new ADDHERE(TM) ... layer onto a substrate of thermoplastic,polyolefin (TPO) for ...
... with Top Children,s Miracle Network Health Experts, SALT LAKE CITY, Oct. 22 /PRNewswire/, ... experts from 170 Children,s ... questions about Methicillin-resistant Staphylococcus Aureus ... to antibiotics, and other ...
... Chairman Howard Dean issued the following statement in response,to ... $46 billion,in war spending, for a total of $196 ... coverage to 10 million of America,s low income children:, ... to fund his war of,choice in Iraq but has ...
... There,s no proof cancer will spread to the ... (HealthDay News) -- Women diagnosed with breast cancer who ... other, healthy breast removed as a preventive measure. , ... mastectomy, more than doubled from 1998 to 2003, according ...
... 22 The start of the,patent lawsuit by VNUS(R) ... laser competitors, Diomed, AngioDynamics and Vascular,Solutions, has been delayed ... delay is due to a busy court calendar. A ... new trial start dates. At,the conference, the parties will ...
... 22 Dialysis Corporation,of America (Nasdaq: DCAI ... third,quarter 2007 earnings after the close of the ... of America owns and operates freestanding kidney,hemodialysis centers ... Carolina and Virginia, and provides in-hospital,dialysis services on ...
Cached Medicine News:Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4Health News:Children's Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection 2Health News:More Women Choosing 'Preventive' Double Mastectomy 2Health News:More Women Choosing 'Preventive' Double Mastectomy 3Health News:Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
...
...
...
Medicine Products: